Skip to main content
search
Category

Membership News Archive

Membership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Nexperia Semiconductor Supply Exposure — feedback for DHSC

DHSC have highlighted an emerging risk to the UK medical technology supply chain following recent developments involving Nexperia, a major global supplier of legacy semiconductors. The Dutch government’s recent intervention and the subsequent Chinese export ban on Nexperia products have disrupted a significant portion of the company’s supply chain, with potential implications for the availability of critical chips used in…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

NICE recruiting HealthTech professional committee members

NICE have a number of roles available across their three HealthTech Committees: Diagnostics advisory committee Medical technologies advisory committee Interventional procedures advisory committee Applicants may be appointed to any of the three committees, unless otherwise indicated during the interview process. They are particularly interested in candidates with experience in the following areas: NHS manager/NHS finance manager (multiple roles) Nurse or…
Ben Kemp
October 28, 2025
ConsultationsConsultations ArchiveMembership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

AI Growth Lab: Call for Evidence

The MHRA are seeking evidence on a pioneering cross-economy sandbox, that would oversee the deployment of AI-enabled products and services that current regulation hinders. The Lab would deliver more dynamic UK regulation. Regulatory decisions on novel technologies can often take years, but we know that regulatory sandboxes can accelerate time to market by 40%. The AI Growth Lab would support…
Ben Kemp
October 28, 2025
Infectious Diseases Working PartyInfectious Diseases Working Party ArchiveMembership NewsMembership News ArchiveNear Patient Testing Working PartyNear Patient Testing Working Party Archive

Infectious Diseases and Near Patient Working Party Agendas – 6th November

The Infectious Diseases and Near Patient Working Parties are taking place back-to-back on Thursday 6th November. The Infectious Diseases Working Party agenda can be found here. Highlights include presentations on: Advancing the 100 Days Mission for Diagnostics: 2025 Global Gap Assessment Tuberculosis at home and away: diagnostic progress, pitfalls and prospects Update from the Fleming Initiative Register here. The Near…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

First meeting of National Commission into the Regulation of AI in Healthcare

Last week, the MHRA convened the National Commission into the Regulation of AI in Healthcare for the first time. The Commission brings together global AI leaders, clinicians, regulators, and patient advocates to advise on future-ready frameworks for regulation of AI in health. BIVDA is a member of the Technology Working Group as part of the commission, represented by our Head…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

NHSE Detailed Market Sounding – April 2027 Scope 3 Reporting and Target Setting: Feedback Session

NHS England’s Net Zero and Sustainable Procurement Team will share a summary of the feedback received in the Detailed Market Sounding - Scope 3 target setting and reporting and outline the next steps. The event will take place on 17 November 2025 at 3:00pm – 3:45pm. You can register here. Please note the joining link will be shared the morning…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

OLS funding for NIHR-led trial to assess the clinical and cost effectiveness of the use of multi-cancer detection (MCD) tests in primary care

The Office for Life Sciences is providing funding for an NIHR-led trial to assess the clinical and cost effectiveness of the use of multi-cancer detection (MCD) tests in primary care to triage patients with non-specific abdominal symptoms for urgent cancer investigation. If you are interested in applying, you are strongly encouraged to attend the workshop taking place virtually on 21…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

Last Chance: BIVDA Member Survey

  This is the last chance for members to submit feedback (via this survey) on BIVDA's performance. Your feedback is essential to help us understand our successes and also evaluate where we can improve our services for members. We are grateful to the 30+ individuals who have provided their views on our organisation, but we urge more members to complete…
Ben Kemp
October 28, 2025
Membership NewsMembership News Archive

NHS hospitals trialling BIVDA member’s 15-minute blood test for life-threatening conditions in children

An innovative 15-minute blood test developed by BIVDA member MeMed is being trialled by the NHS this winter to help doctors rapidly identify potentially life-threatening infections in children. The cutting-edge MeMed BV test can distinguish between bacterial and viral infections far faster than traditional laboratory methods. This speed could prove crucial in detecting serious conditions such as sepsis or meningitis,…
Ben Kemp
October 27, 2025
Membership NewsMembership News Archive

PEOPLE AMR Network announce small grants call for early- and mid-career researchers (EMCRs)

The PEOPLE AMR Network are excited to announce small grants call for EMCRs, offering up to £144,000 to support innovative, transdisciplinary projects tackling antimicrobial resistance (AMR). You can apply completing the form here. Further information, including helpful application guidance, can be found here. Researchers are able to apply for up to £36,000 to support pump-priming studies, evidence synthesis and other activities aligned…
Ben Kemp
October 22, 2025
Close Menu